Genomic and Metabolomic Advances in the Identification of Disease and Adverse Event Biomarkers

• Spear BB , Heath-ChiozziM, HuffJ: Clinical application of pharmacogenetics.Trends Mol. Med.7, 201–204 (2001).
   PubMed Web of Science ®Google Scholar
• Woodcock J : The prospects for “personalized medicine” in drug development and drug therapy.Clin. Pharmacol. Ther.81, 164–169 (2007).
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. Personalized Health Care: Pioneers, Partnerships, Progress. US Department of Health and Human Services, DC, USA (2008)
   Google Scholar
• Laterza OF , ModurVR, LadensonJH: Biomarkers of tissue injury.Biomarkers Med.2, 81–92 (2008).
   PubMed Web of Science ®Google Scholar
• Goodsaid FM , FruehFW, MattesW: Strategic paths for biomarker qualification.Toxicology245, 219–223 (2008).
   PubMed Web of Science ®Google Scholar
• Mattes WB , WalkerEG: Translational toxicology and the work of the predictive safety testing consortium.Clin. Pharmacol. Ther.85, 327–330 (2009).
   PubMed Web of Science ®Google Scholar
• Mattes WB : Public consortium efforts in toxicogenomics. In: Essential Concepts in Toxicogenomics. Mendrick DL, Mattes WB (Eds). Humana, NJ, USA, 221–238 (2008).
   Google Scholar
• Biomarkers Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin.Pharmacol. Ther.69, 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Leone AM , KaoLM, McMillianMKet al. : Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression.Chem. Res. Toxicol.20, 600–608 (2007).
   PubMed Web of Science ®Google Scholar
• Hultin-Rosenberg L , JagannathanS, NilssonKCet al. : Predictive models of hepatotoxicity using gene expression data from primary rat hepatocytes.Xenobiotica36, 1122–1139 (2006).
   PubMed Web of Science ®Google Scholar
• Buck WR , WaringJF, BlommeEA:. Use of traditional end points and gene dysregulation to understand mechanisms of toxicity: toxicogenomics in mechanistic toxicology. In: Essential Concepts in Toxicogenomics. Mendrick DL, Mattes WB (Eds). Humana, NJ, USA, 23–44 (2008).
   Google Scholar
• Martin R , RoseD, YuK, BarrosS: Toxicogenomics strategies for predicting drug toxicity.Pharmacogenomics7, 1003–1016 (2006).
   PubMed Web of Science ®Google Scholar
• Hunt JL : Molecular pathology in anatomic pathology practice: a review of basic principles.Arch. Pathol. Lab. Med.132, 248–260 (2008).
   PubMed Web of Science ®Google Scholar
• Mendrick DL , DanielsKK: From the bench to the clinic and back again: translational biomarker discovery using in silico mining of pharmacogenomic data.Biomarkers Med.1, 319–333 (2007).
   PubMed Web of Science ®Google Scholar
• Liew CC , MaJ, TangHC, ZhengR, DempseyAA: The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool.J. Lab. Clin. Med.147, 126–132 (2006).
   PubMed Web of Science ®Google Scholar
• Burczynski ME , DornerAJ: Transcriptional profiling of peripheral blood cells in clinical pharmacogenomic studies.Pharmacogenomics7, 187–202 (2006).
   PubMed Web of Science ®Google Scholar
• Sharp FR , XuH, LitLet al. : Genomic profiles of stroke in blood.Stroke38, 691–693 (2007).
   PubMed Web of Science ®Google Scholar
• Sharp FR , XuH, LitLet al. : The future of genomic profiling of neurological diseases using blood.Arch. Neurol.63, 1529–1536 (2006).
   PubMed Web of Science ®Google Scholar
• Segman RH , ShefiN, Goltser-DubnerT, FriedmanN, KaminskiN, ShalevAY: Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors.Mol. Psychiatry10, 500–513 (2005).
   PubMed Web of Science ®Google Scholar
• Burczynski ME , PetersonRL, TwineNCet al. : Molecular classification of Crohn‘s disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.J. Mol. Diagn.8, 51–61 (2006).
   PubMed Web of Science ®Google Scholar
• Bushel PR , HeinlothAN, LiJet al. : Blood gene expression signatures predict exposure levels.Proc. Natl Acad. Sci. USA104, 18211–18216 (2007).
   PubMed Web of Science ®Google Scholar
• Deng MC , EisenHJ, MehraMRet al. : Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling.Am. J. Transplant.6, 150–160 (2006).
   PubMed Web of Science ®Google Scholar
• Fang KC : Clinical utilities of peripheral blood gene expression profiling in the management of cardiac transplant patients.J. Immunotoxicol.4, 209–217 (2007).
   PubMed Web of Science ®Google Scholar
• Tang Y , XuH, DuXet al. : Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study.J. Cereb. Blood Flow Metab.26, 1089–1102 (2006).
   PubMed Web of Science ®Google Scholar
• Moore DF , LiH, JeffriesNet al. : Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation.Circulation111, 212–221 (2005).
   PubMed Web of Science ®Google Scholar
• Xu H , TangY, LiuDZet al. : Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke.J. Cereb. Blood Flow Metab.28, 1320–1328 (2008).
   PubMed Web of Science ®Google Scholar
• Wang K , ZhangS, MarzolfBet al. : Circulating microRNAs, potential biomarkers for drug-induced liver injury.Proc. Natl Acad. Sci. USA106, 4402–4407 (2009).
   PubMed Web of Science ®Google Scholar
• Miyamoto M , YanaiM, OokuboS, AwasakiN, TakamiK, ImaiR: Detection of cell-free, liver-specific mRNAs in peripheral blood from rats with hepatotoxicity: a potential toxicological biomarker for safety evaluation.Toxicol. Sci.106, 538–545 (2008).
   PubMed Web of Science ®Google Scholar
• Heidecker B , HareJM: The use of transcriptomic biomarkers for personalized medicine.Heart Fail. Rev.12, 1–11 (2007).
   PubMed Web of Science ®Google Scholar
• von Stein P , LofbergR, KuznetsovNVet al. : Multigene analysis can discriminate between ulcerative colitis, Crohn‘s disease, and irritable bowel syndrome.Gastroenterology134, 1869–1881 (2008).
   PubMed Web of Science ®Google Scholar
• Fielden MR , NieA, McMillianMet al. : Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat.Toxicol. Sci.103, 28–34 (2008).
   PubMed Web of Science ®Google Scholar
• Ichimura T , BonventreJV, BaillyVet al. : Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.J. Biol. Chem.273, 4135–4142 (1998).
   PubMed Web of Science ®Google Scholar
• Shi L , ReidLH, JonesWDet al. : The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.Nat. Biotechnol.24, 1151–1161 (2006).
   PubMed Web of Science ®Google Scholar
• Guo L , LobenhoferEK, WangCet al. : Rat toxicogenomic study reveals analytical consistency across microarray platforms.Nat. Biotechnol.24, 1162–1169 (2006).
   PubMed Web of Science ®Google Scholar
• Patterson TA , LobenhoferEK, Fulmer-SmentekSBet al. : Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project.Nat. Biotechnol.24, 1140–1150 (2006).
   PubMed Web of Science ®Google Scholar
• Canales RD , LuoY, WilleyJCet al. : Evaluation of DNA microarray results with quantitative gene expression platforms.Nat. Biotechnol.24, 1115–1122 (2006).
   PubMed Web of Science ®Google Scholar
• Fiehn O : Metabolomics: the link between genotypes and phenotypes.Plant Mol. Biol.48, 155–171 (2002).
   PubMed Web of Science ®Google Scholar
• Nicholson JK , LindonJC, HolmesE: ‘Metabonomics‘: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.Xenobiotica29, 1181–1189 (1999).
   PubMed Web of Science ®Google Scholar
• Lindon JC , NicholsonJK, EverettJR: NMR spectroscopy of biofluids. In: Annual Review of NMR Spectroscopy. Webb GA (Ed.). Academic Press, SD, USA, 2–88 (1999).
   Google Scholar
• Chan EC , KohPK, MalMet al. : Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).J. Proteome Res.8, 352–361 (2009).
   PubMed Web of Science ®Google Scholar
• Sreekumar A , PoissonLM, RajendiranTMet al. : Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.Nature457, 910–914 (2009).
   PubMed Web of Science ®Google Scholar
• Craig A , SidawayJ, HolmesEet al. : Systems toxicology: integrated genomic, proteomic and metabonomic analysis of methapyrilene induced hepatotoxicity in the rat.J. Proteome Res.5, 1586–1601 (2006).
   PubMed Web of Science ®Google Scholar
• Coen M , HongYS, ClaytonTAet al. : The mechanism of galactosamine toxicity revisited; a metabonomic study.J. Proteome Res.6, 2711–2719 (2007).
   PubMed Web of Science ®Google Scholar
• Robertson DG , DattaK, WellsDet al. : Metabonomic evaluation of metabolic dysregulation in rats induced by PF 376304, a novel inhibitor of phosphoinositide 3-kinase.Chem. Res. Toxicol.20, 1871–1877 (2007).
   PubMed Web of Science ®Google Scholar
• Sun J , SchnackenbergLK, HollandRDet al. : Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.871, 328–340 (2008).
   PubMed Web of Science ®Google Scholar
• Chan W , CaiZ: Aristolochic acid induced changes in the metabolic profile of rat urine.J. Pharm. Biomed. Anal.46, 757–762 (2008).
   PubMed Web of Science ®Google Scholar
• Espandiari P , ZhangJ, SchnackenbergLKet al. : Age-related differences in susceptibility to toxic effects of valproic acid in rats.J. Appl. Toxicol.28, 628–637 (2008).
   PubMed Web of Science ®Google Scholar
• Wei L , LiaoP, WuHet al. : Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum.Toxicol. Appl. Pharmacol.227, 417–429 (2008).
   PubMed Web of Science ®Google Scholar
• Park JC , HongYS, KimYJet al. : A metabonomic study on the biochemical effects of doxorubicin in rats using 1H-NMR spectroscopy.J. Toxicol. Environ. Health Pt A72, 374–384 (2009).
   PubMed Web of Science ®Google Scholar
• Schnackenberg LK , ChenM, SunJet al. : Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies.Toxicol. Appl. Pharmacol.235, 25–32 (2009).
   PubMed Web of Science ®Google Scholar
• Wei L , LiaoP, WuHet al. : Metabolic profiling studies on the toxicological effects of realgar in rats by 1H NMR spectroscopy.Toxicol. Appl. Pharmacol.234, 314–325 (2009).
   PubMed Web of Science ®Google Scholar
• Boudonck KJ , MitchellMW, NemetLet al. : Discovery of metabolomics biomarkers for early detection of nephrotoxicity.Toxicol. Pathol.37, 280–292 (2009).
   PubMed Web of Science ®Google Scholar
• Portilla D , LiS, NagothuKKet al. : Metabolomic study of cisplatin-induced nephrotoxicity.Kidney Int.69, 2194–2204 (2006).
   PubMed Web of Science ®Google Scholar
• Lindon JC , NicholsonJK, HolmesEet al. : Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.Toxicol. Appl. Pharmacol.187, 137–146 (2003).
   PubMed Web of Science ®Google Scholar
• Lindon JC , KeunHC, EbbelsTM, PearceJM, HolmesE, NicholsonJK: The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements.Pharmacogenomics6, 691–699 (2005).
   PubMed Web of Science ®Google Scholar
• Ebbels TM , KeunHC, BeckonertOPet al. : Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.J. Proteome Res.6, 4407–4422 (2007).
   PubMed Web of Science ®Google Scholar
• Barba I , Fernandez-MontesinosR, Garcia-DoradoD, PozoD: Alzheimer‘s disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.J. Cell Mol. Med.12, 1477–1485 (2008).
   PubMed Web of Science ®Google Scholar
• Serkova NJ , VanRZ, TobiasM, PitzerJE, WilkinsonJE, StringerKA: Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury.Am. J. Physiol. Lung Cell. Mol. Physiol.295, L152–L161 (2008).
   PubMed Web of Science ®Google Scholar
• Altmaier E , RamsaySL, GraberA, MewesHW, WeinbergerKM, SuhreK: Bioinformatics analysis of targeted metabolomics – uncovering old and new tales of diabetic mice under medication.Endocrinology149, 3478–3489 (2008).
   PubMed Web of Science ®Google Scholar
• van Ginneken V , VerheyE, PoelmannRet al. : Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis.Biochim. Biophys. Acta1771, 1263–1270 (2007).
   PubMed Web of Science ®Google Scholar
• Holmes E , TsangTM, TabriziSJ: The application of NMR-based metabonomics in neurological disorders.NeuroRx3, 358–372 (2006).
   PubMedGoogle Scholar
• Tsang TM , WoodmanB, McLoughlinGAet al. : Metabolic characterization of the R6/2 transgenic mouse model of Huntington‘s disease by high-resolution MAS 1H NMR spectroscopy.J. Proteome Res.5, 483–492 (2006).
   PubMed Web of Science ®Google Scholar
• Moolenaar SH , EngelkeUF, WeversRA: Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism.Ann. Clin. Biochem.40, 16–24 (2003).
   PubMed Web of Science ®Google Scholar
• Kim K , AronovP, ZakharkinSOet al. : Urine metabolomics analysis for kidney cancer detection and biomarker discovery.Mol. Cell. Proteomics8, 558–570 (2009).
   PubMed Web of Science ®Google Scholar
• Spratlin JL , SerkovaNJ, EckhardtSG: Clinical applications of metabolomics in oncology: a review.Clin. Cancer Res.15, 431–440 (2009).
   PubMed Web of Science ®Google Scholar
• Wishart DS : Metabolomics: a complementary tool in renal transplantation.Contrib. Nephrol.160, 76–87 (2008).
   PubMed Web of Science ®Google Scholar
• Barba I , deLG, MartinEet al. : Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease.Magn. Reson. Med.60, 27–32 (2008).
   PubMed Web of Science ®Google Scholar
• Coen M , O‘SullivanM, BubbWA, KuchelPW, SorrellT: Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis.Clin. Infect. Dis.41, 1582–1590 (2005).
   PubMed Web of Science ®Google Scholar
• Brindle JT , AnttiH, HolmesEet al. : Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.Nat. Med.8, 1439–1444 (2002).
   PubMed Web of Science ®Google Scholar
• Dunne VG , BhattachayyaS, BesserM, RaeC, GriffinJL: Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study.NMR Biomed.18, 24–33 (2005).
   PubMed Web of Science ®Google Scholar
• Maguire G , LeeP, ManheimD, BorosL: SiDMAP: a metabolomics approach to assess the effects of drug candidates on the dynamic properties of biochemical pathways.Expert Opin. Drug Discov.1, 351–359 (2006).
   PubMed Web of Science ®Google Scholar
• Koulman A , LaneGA, HarrisonSJ, VolmerDA: From differentiating metabolites to biomarkers.Anal. Bioanal. Chem.394, 663–670 (2009).
   PubMed Web of Science ®Google Scholar
• Yang J , ZhaoX, LiuXet al. : High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B.J. Proteome Res.5, 554–561 (2006).
   PubMed Web of Science ®Google Scholar
• Spivey JR , BronkSF, GoresGJ: Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium.J. Clin. Invest.92, 17–24 (1993).
   PubMed Web of Science ®Google Scholar
• Yin P , ZhaoX, LiQ, WangJ, LiJ, XuG: Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS).J. Proteome Res.5, 2135–2143 (2006).
   PubMed Web of Science ®Google Scholar
• Soga T , BaranR, SuematsuMet al. : Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption.J. Biol. Chem.281, 16768–16776 (2006).
   PubMed Web of Science ®Google Scholar
• Beger RD , HollandRD, SunJet al. : Metabonomics of acute kidney injury in children after cardiac surgery.Pediatr. Nephrol.23(6), 977–984 (2008).
   PubMed Web of Science ®Google Scholar
• Wishart DS : Metabolomics in monitoring kidney transplants.Curr. Opin. Nephrol. Hypertens.15, 637–642 (2006).
   PubMed Web of Science ®Google Scholar
• Clayton TA , LindonJC, EverettJRet al. : An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria.Arch. Toxicol.77, 208–217 (2003).
   PubMed Web of Science ®Google Scholar
• Clayton TA , LindonJC, EverettJRet al. : Hepatotoxin-induced hypercreatinaemia and hypercreatinuria: their relationship to one another, to liver damage and to weakened nutritional status.Arch. Toxicol.78, 86–96 (2004).
   PubMed Web of Science ®Google Scholar
• Schnackenberg LK , DraganYP, ReilyMD, RobertsonDG, BegerRD: Evaluation of NMR spectral data of urine in conjunction with measured clinical chemistry and histopathology parameters to assess the effects of liver and kidney toxicants.Metabolomics3, 87–100 (2007).
   Web of Science ®Google Scholar
• Woo HM , KimKM, ChoiMHet al. : Mass spectrometry based metabolomic approaches in urinary biomarker study of women‘s cancers.Clin. Chim. Acta400, 63–69 (2009).
   PubMed Web of Science ®Google Scholar
• Beger R , SchnackenbergL, HollandR, LiD, DraganY: Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma.Metabolomics2, 125–134 (2006).
   Web of Science ®Google Scholar
• Saude EJ , ObiefunaIP, SomorjaiRLet al. : Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance.Am. J. Respir. Crit. Care Med.179, 25–34 (2009).
   PubMed Web of Science ®Google Scholar
• Li X , XuZ, LuXet al. : Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: biomarker discovery for diabetes mellitus.Anal. Chim. Acta633, 257–262 (2009).
   PubMed Web of Science ®Google Scholar
• Weljie AM , DowlatabadiR, MillerBJ, VogelHJ, JirikFR: An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy.J. Proteome Res.6, 3456–3464 (2007).
   PubMed Web of Science ®Google Scholar
• Goodsaid FM , FruehFW: Biomarker qualification pilot process at the US Food and Drug Administration.AAPS J.9, E105–E108 (2007).
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R , KristalBS, WeinshilboumRM: Metabolomics: a global biochemical approach to drug response and disease.Annu. Rev. Pharmacol. Toxicol.48, 653–683 (2008).
   PubMed Web of Science ®Google Scholar
• Wishart DS : Applications of metabolomics in drug discovery and development.Drugs R. D.9, 307–322 (2008).
   PubMed Web of Science ®Google Scholar
• Trygg J , HolmesE, LundstedtT: Chemometrics in metabonomics.J. Proteome Res.6, 469–479 (2007).
   PubMed Web of Science ®Google Scholar
• Wishart DS : Quantitative metabolomics using NMR.Trends Analyt. Chem27, 228–237 (2008).
   Web of Science ®Google Scholar
• Clarke CJ , HaseldenJN: Metabolic profiling as a tool for understanding mechanisms of toxicity.Toxicol. Pathol.36, 140–147 (2008).
   PubMed Web of Science ®Google Scholar
• Brazma A , HingampP, QuackenbushJet al. : Minimum information about a microarray experiment (MIAME) – toward standards for microarray data.Nat. Genet.29, 365–371 (2001).
   PubMed Web of Science ®Google Scholar
• Fiehn O , RobertsonD, GriffinJet al. : The metabolomics standards initiative (MSI).Metabolomics3, 175–178 (2007).
   Web of Science ®Google Scholar
• Sansone SA , FanT, GoodacreRet al. : The metabolomics standards initiative.Nat. Biotechnol.25, 846–848 (2007).
   PubMed Web of Science ®Google Scholar
• Evans RW , WilliamsGE, BaronHMet al. : The economic implications of noninvasive molecular testing for cardiac allograft rejection.Am. J. Transplant.5, 1553–1558 (2005).
   PubMed Web of Science ®Google Scholar
• Deverka PA : Pharmacogenomics, evidence, and the role of payers.Public Health Genomics12, 149–157 (2009).
   PubMed Web of Science ®Google Scholar
• Wang Z , GersteinM, SnyderM: RNA-Seq: a revolutionary tool for transcriptomics.Nat. Rev. Genet.10, 57–63 (2009).
   PubMed Web of Science ®Google Scholar

▪ Websites

• US FDA‘s Critical Path Report and List. www.fda.gov/oc/initiatives/criticalpath
   Google Scholar
• European Medicines Agency (EMEA): definition of a genomics biomarker. www.emea.europa.eu/pdfs/human/ich/43798606en.pdf
   Google Scholar
• European Medicines Agency (EMEA): rat urinary protein protein biomarkers announcement. www.emea.europa.eu/pdfs/human/biomarkers/25088508en.pdf
   Google Scholar
• Consortia: Critical Path Institute. www.c-path.org/consortia.cfm
   Google Scholar
• ILSI: Health and Environmental Science Institute. www.hesiglobal.org/i4a/pages/index.cfm?pageid=3279
   Google Scholar
• FDA: Table of valid genomic biomarkers in the context of approved drug labels. www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm
   Google Scholar
• Office of Biotechnology Activities: Report from the Department of Health and Human Services USA.. http://oba.od.nih.gov/oba/SACGHS/reports/SACGHS_PGx_report.pdf
   Google Scholar